Comparison of Cytology and Nuclear Matrix Protein 22 for the Detection and Follow-Up of Bladder Cancer

Publisher： Karger

E-ISSN： 1423-0399|66|2|72-77

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.66, Iss.2, 2001-02, pp. : 72-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer—institutional experience and review

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 4, 2015-04 ,pp. : 307-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostic Value of the Nuclear Matrix Protein 22 Test and Urine Cytology in Upper Tract Urothelial Tumors

By  

Urologia Internationalis, Vol. 87, Iss. 2, 2011-08 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

Evaluation of urovysion and cytology for bladder cancer detection

By  

CANCER CYTOPATHOLOGY, Vol. 121, Iss. 10, 2013-10 ,pp. : 591-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Nuclear Matrix Protein 22 and Survivin Baseline Level in Patients after Radical Cystectomy

By  

Urologia Internationalis, Vol. 87, Iss. 4, 2011-11 ,pp. : 445-449

Karger

Access to resources Recommend Favorite

Determination of a New Cut-Off Value for the Urinary BTAtrak to Optimize the Detection of Recurrences in the Follow-Up of Patients with Superficial Bladder Carcinoma

By  

Current Urology, Vol. 1, Iss. 1, 2007-09 ,pp. : 42-47

Karger

Access to resources Recommend Favorite